MEDICAL MARIJUANA, INC. INVESTMENT AXIM® BIOTECHNOLOGIES, INC. PUBLISHES PRODUCT PIPELINE CHART FOR PHARMA CLINICAL TRIALS PROGRAM IN CANNABINOID R&D

MEDICAL MARIJUANA, INC. INVESTMENT AXIM® BIOTECHNOLOGIES, INC. PUBLISHES PRODUCT PIPELINE CHART FOR PHARMA CLINICAL TRIALS PROGRAM IN CANNABINOID R&D

Cannabinoid Innovator’s Product Pipeline Highlights Timelines of Its Intellectual Property (IP) Protected Cannabinoid-Based Products from Pre-Clinical to NDA for Multiple Indications    NEW YORK – Nov. 3, 2016 – Medical Marijuana, Inc. (OTC: MJNA) today announced that...
Giving Back: Hope4Harper

Giving Back: Hope4Harper

[vc_row][vc_column][vc_column_text]From time to time, we come across families who have found a way to generously give back to their community at large, despite their own complicated circumstances. These families have a special place in our hearts, especially because...